Literature DB >> 8290248

Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2 as an inhibitor.

S Takada1, H Kido, A Fukutomi, T Mori, K Koike.   

Abstract

X protein of hepatitis B virus (HBV) transactivates transcription of various viral and cellular genes. It has been suggested that X protein plays a major role in hepatocarcinogenesis by HBV. The protein possesses amino acid sequence homology to the functionally essential domain of Kunitz-type serine protease inhibitors. This Kunitz domain-like sequence in X protein is indispensable for the transactivation function. To clarify whether X protein has a serine protease inhibitor activity, a search was made for serine proteases which interact with, but not degrade X protein. Tryptase TL2, one of serine proteases in hepatic cells, was found to directly interact with X protein without degradation. Moreover, the activities of tryptase TL2 and an analogous protease were substantially inhibited by X protein. These results suggest that transactivation function of X protein is exerted by modulation of the hepatic serine protease activity, giving rise to quantitative or qualitative change of cellular transcription factor(s) through protection from proteolytic degradation and/or suppression of processing.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8290248

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  The hepatitis B virus X gene induces p53-mediated programmed cell death.

Authors:  P Chirillo; S Pagano; G Natoli; P L Puri; V L Burgio; C Balsano; M Levrero
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-22       Impact factor: 11.205

2.  XAP2, a novel hepatitis B virus X-associated protein that inhibits X transactivation.

Authors:  N Kuzhandaivelu; Y S Cong; C Inouye; W M Yang; E Seto
Journal:  Nucleic Acids Res       Date:  1996-12-01       Impact factor: 16.971

3.  The X protein of hepatitis B virus coactivates potent activation domains.

Authors:  I Haviv; D Vaizel; Y Shaul
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

Review 4.  Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma.

Authors:  M A Feitelson; L X Duan
Journal:  Am J Pathol       Date:  1997-04       Impact factor: 4.307

5.  Hepatitis B virus X protein interferes with cellular DNA repair.

Authors:  S A Becker; T H Lee; J S Butel; B L Slagle
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

6.  A revised secondary structure model for the 3'-end of hepatitis B virus pregenomic RNA.

Authors:  A H Kidd; K Kidd-Ljunggren
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

7.  A truncated mutant (residues 58-140) of the hepatitis B virus X protein retains transactivation function.

Authors:  V Kumar; N Jayasuryan; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

8.  Nuclear respiratory factor 1 plays an essential role in transcriptional initiation from the hepatitis B virus x gene promoter.

Authors:  Yumiko Tokusumi; Sharleen Zhou; Shinako Takada
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Hepatitis B virus pX activates NF-kappa B-dependent transcription through a Raf-independent pathway.

Authors:  P Chirillo; M Falco; P L Puri; M Artini; C Balsano; M Levrero; G Natoli
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Direct interaction of the hepatitis B virus HBx protein with p53 leads to inhibition by HBx of p53 response element-directed transactivation.

Authors:  R Truant; J Antunovic; J Greenblatt; C Prives; J A Cromlish
Journal:  J Virol       Date:  1995-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.